Back to
Bank of New York Mellon Corp
CHRS28 quarters
Position history for
Bank of New York Mellon Corp's holdings in COHERUS ONCOLOGY INC
Yes. Bank of New York Mellon holds 319,687 shares of CHRS (Coherus Oncology), worth $447,563, as of its Q2 2026 13F filing. It increased the position by 34,654 shares (+12.2%) from Q1 2026. Bank of New York Mellon has held CHRS in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$447,563
Current Shares
319,687
Total Value Change
-$5.1M
Total Shares Change
+46,948
Quarter-by-Quarter History
Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP